BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10479666)

  • 21. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes.
    Sánchez-Quesada JL; Vinagre I; De Juan-Franco E; Sánchez-Hernández J; Bonet-Marques R; Blanco-Vaca F; Ordóñez-Llanos J; Pérez A
    Cardiovasc Diabetol; 2013 Aug; 12():112. PubMed ID: 23915379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
    Bagdade JD; Subbaiah PV
    Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.
    Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.
    Brites FD; Cavallero E; de Geitere C; Nicolaïew N; Jacotot B; Rosseneu M; Fruchart JC; Wikinski RL; Castro GR
    Clin Chim Acta; 1999 Jan; 279(1-2):1-14. PubMed ID: 10064113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
    Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
    Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
    Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemoglobin A1 correlates with the ratio of low-to high-density-lipoprotein cholesterol in normal weight type II diabetics.
    Schmitt JK; Poole JR; Lewis SB; Shore VG; Maman A; Baer RM; Forsham PH
    Metabolism; 1982 Nov; 31(11):1084-9. PubMed ID: 6752640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA; Patti L; Romano G; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High density lipoprotein composition in insulin-dependent diabetes mellitus.
    Eckel RH; Albers JJ; Cheung MC; Wahl PW; Lindgren FT; Bierman EL
    Diabetes; 1981 Feb; 30(2):132-8. PubMed ID: 6781957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
    Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
    Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes.
    Phillips C; Owens D; Collins P; Tomkin GH
    Atherosclerosis; 2005 Jul; 181(1):109-14. PubMed ID: 15939061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
    Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF
    Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.